Clinical Trial Update: Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman. [Phase 3]

View source ↗

Summary

A phase 3 randomized double-blind trial evaluated the benefit of spironolactone for treating acne in adult women (Acne vulgaris).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Nantes University Hospital | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED